Letter from the Industry: The EU Biotech Act II

Europe’s biosolutions industry is ready to scale, but EU policymaking is not moving fast enough. In this joint letter, the Europe Biosolutions Coalition, with industry organisations from across Europe, urge the Commission to ensure that Biotech Act II delivers a clear, horizontal framework that enables deployment, scale‑up and investment across sectors.

Addressed to Executive Vice‑President Stéphane Séjourné, the letter sends a strong political signal at a decisive moment in the Commission’s preparatory work, underlining why Biotech Act II must remain ambitious, distinct and focused on Europe’s industrial competitiveness.